Literature DB >> 2566602

Incorporation of monoclonal antibodies into cells by osmotic permeabilization. Effect on cellular metabolism.

R Chakrabarti1, N E Pfeiffer, D E Wylie, S M Schuster.   

Abstract

Incorporation of asparagine synthetase-specific monoclonal antibodies into L5178Y D10/R (L-asparaginase-resistant) murine lymphoma cells by osmotic lysis of pinocytic vesicles was used to evaluate the potential of the technique for macromolecular incorporation for metabolic studies. Nonspecific effects of the incorporation procedure included temporary inhibition of protein and DNA synthesis by 80-85% and a transitory loss of membrane integrity. Cells incorporated with an antibody inhibitory to tumor cell asparagine synthetase showed increased dependence upon an exogenous source of asparagine in the culture medium, while cells incorporated with a control antibody were not affected. These studies demonstrated that incorporation of inhibitory monoclonal antibodies into cells can be used to study the short term metabolic role of specific enzymes; however, the metabolic effects induced by the specific macromolecule must be evaluated within the context of the nonspecific effects caused by the osmotic treatment required for incorporation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566602

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

Authors:  C P Leamon; P S Low
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Triplex DNA in the nucleus: direct binding of triplex-specific antibodies and their effect on transcription, replication and cell growth.

Authors:  Y M Agazie; G D Burkholder; J S Lee
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

3.  Single quantum dot tracking reveals the impact of nanoparticle surface on intracellular state.

Authors:  Mohammad U Zahid; Liang Ma; Sung Jun Lim; Andrew M Smith
Journal:  Nat Commun       Date:  2018-05-08       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.